We recently reported that HDAC3 promotes liver regeneration and boosts HCC cell proliferation by increasing IL-6-STAT3 activation [18], which suggested that IL-6 signalling might be aberrantly activated in female mice when HDAC3 is selectively deleted in the liver. The gene discussed is STAT3; the disease is hepatocellular carcinoma.